Clinical Trial Update: Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver Metastases [Phase 4]

View source ↗

Summary

Phase 4 trial update describes a model to predict efficacy of cetuximab and bevacizumab in colorectal cancer with liver metastases. The study status is terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• ERBITUX (cetuximab)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Colorectal Cancer, Neoplasm Metastasis | Phase 4 | Status: TERMINATED